Establishing peripheral i.v. access is an invasive procedure critical to medical care. Despite this, clinicians and researchers know little about the characteristics of having many or few veins aside from anecdotal reports and experiences. Surprisingly, there is currently no literature about the number of veins visible in patients or the patient characteristics associated with difficult i.v. access. Previous studies reported various factors that affect vein visibility required for vein cannulation, but none has investigated patient characteristics and skin colour specifically. 1 -7 Our study investigated patient characteristics associated with finding veins eligible for cannulation. As life expectancy increases and patients have more procedures throughout their lifetime, vein preservation is seen as a vital long-term task. A device or technique that helps reduce cannulation attempts would be one step towards vein preservation. Technical advances and substantial research have allowed healthcare providers to improve the ease and speed of placing i.v. catheters. 4 7-9 Some studies have focused on techniques and devices to improve vein visibility. Our study examined visualization of superficial veins with a new infrared technology. There are several devices using this technology including the AccuVein w and VeinViewer w . We chose to study the VueTek Scientific Veinsite that was designed to improve the visualization of superficial veins. This is the first study for this particular device.
There were two objectives of this study. First, we investigated the patient characteristic factors that correlate with identification of vein cannulation sites with the conventional method (CM) or first accurate visual check. Secondly, we sought to evaluate the new infrared vein finding (VF) technology device in identifying i.v. cannulation sites on the upper extremity. We hypothesized that obesity, dark skin colour, and younger age would be associated with finding fewer veins. We also proposed that the infrared technology would allow finding of more potential cannulation sites.
Methods
After receiving Institutional Review Board approval, a randomized prospective study was conducted on volunteer subjects at a large urban medical centre, St Luke's-Roosevelt Hospital Center. Study participants included males and females of all ages, irrespective of race or ethnicity. Excluded conditions were emergency surgeries or pregnancy. Before involvement in the study, written informed consent was obtained from all subjects or their parents if subjects were under the age of 18 or unemancipated minors. Patient characteristic information including age, gender, height (inches), weight (pounds), ethnicity, and skin colour (Von Luschan's chromatic scale) 10 was collected from each study participant. Observers, including phlebotomists, physicians, and nurses skilled in venipuncture, examined a minimum of 10 independent subjects each. Difficult cases were defined as zero or one vein visible by the CM. We inspected the upper extremities, defined as the forearm and hand distal to the elbow crease, of all subjects for possible venipuncture sites. Each subject underwent two observations: one using the CM and the other with the VF device. When the order called for CM, we used normal, unassisted eyesight. With the VF condition, we used the head-mounted VueTek Veinsite TM system (Grey, ME, USA), which included a portable near-infrared (NIR) emitter, video acquisition, and display device (Fig. 1) . The company did not participate in the formation, design, implementation, or reporting of the study. The VF uses a rechargeable battery, and also has an optional VGA cable for separate monitor display. The device allows for concurrent vein inspection with normal eyesight and operates independently of ambient light conditions. When powered on, it emits NIR radiation (range, 700 -900 nm), penetrating human anatomy deeper than visible light (,700 nm). Upon contact with tissue, NIR light (tissue absorption coefficient between 0.02 and 0.3 cm 21 ) scatters, travelling a depth of ,5 mm before deviating from its initial direction. 11 Conversely, haemoglobin and other vascular fluids are highly absorptive. The Veinsite's electro-optical technology detects the absorption difference between vascular structures and surrounding tissue. After converting the raw image to greyscale, it then displays it on the headset's LCD screen (Figs 2 and 3 ). Consequently, the user experiences a near real time, enhanced video of the vascular system. 12 The CM and VF sequence was pre-determined by a computerized random number generator and not revealed to the subject or operator until the actual observation. Upon request, the subject exposed a single upper extremity. The observer then rotated the upper extremity and hand while counting the number of visible veins eligible for cannulation. Each continuous vein was counted as one cannulation site. Each operator counted out loud the number of veins seen, and a research assistant then recorded this number. Using the same arm, the next method in the sequence was implemented. Both CM and VF methods required an unobstructed view of the subject's arm under standard hospital lighting conditions. Direct skin contact and the use of tourniquets were strictly avoided. There was no vein diameter, length, or joint criteria. It was an experienced operator counting the sites they felt would be suitable for cannulation.
For the VF method, each observer was trained in the proper use of the device at a training session before examining their first subject. Before examining any subjects, operators were shown the device. The power button, viewing lens, and head strap adjustment knobs were identified. The operator was then allowed to look at the device and place it on the head. After adjusting the head strap, they then were able to examine two volunteers' arms to become familiar with device use. Comfort and ergonomic ratings were recorded, and feedback on the device was solicited. Research assistants recorded the time from the mounting of VF device to its operation for each study subject.
Statistical analysis
The Analyze-it add-in for Microsoft Excel (Redmond, WA, USA) provided the analysis used for the study. BMI was defined as weight (lb) (Table 1) . Our sample population exhibited an overall average of 5.8 (95% CI 5.4-6.2) veins using CM. ANOVA population comparisons suggested significant differences between age (P,0.0001), BMI (P,0.0001), and ethnicity (P,0.008) subgroups. Across all patient characteristic groups, vein detection was the lowest among infants ,6 months [0.9 (95% CI 0.7-1.1) veins] and infants .6 months [2.3 (95% CI 2.0-2.6) veins]. They averaged 4.9 and 3.5, respectively, fewer veins than the population average of 5.8 (95% CI 5.4-6.2). Regression modelling suggested a positive correlation between overall age and visible vein count ( Fig. 4 ; r¼0.27, P,0.0001). As a whole, CM vein visualization showed a substantial decline among obese (Table 2 ). In particular, the morbidly obese exhibited only 3.6 (95% CI 1.5-5.8) veins.
Of the 384 subjects observed, 32 (8.3%) were considered difficult cases: nine subjects with no visible vascular structures and 23 with only one (Table 3) . Age (P,0.0001), BMI (P¼0.034), skin colour (P¼0.0014), and ethnicity (P¼0.0146) subgroups all showed a significant difference from their expected Pearson x 2 percentage values. Infant (50%), African-American (18.3%), Asian (9.1%), multiracial (20%), obese (10.5%), underweight (20.6%), and dark skinned subgroups (14.3%) exhibited a proportionally higher than expected number of difficult cases within their respective patient characteristics (Fig. 5) .
The VF technology identified an average of 9.1 (95% CI 8.6-9.5) possible cannulation sites. Compared with CM, the overall 3) veins with VF from 3.6 (95% CI 1.5-5.8) with CM. In other groups, the VF identified the following number of veins: males 9.7 (95% CI 8.9-10.4), females 8.7 (95% CI 8.1-9.2), infants 3.4 (95% CI 2.7-4.0), child/adolescent 7.7 (95% CI 6.1-9.3), young adult 9.0 (95% CI 8.3-9.8), middle-aged adults 9.9 (95% CI 9.2-10.6), elderly 10.0 (95% CI 8.8-11.2), lighter skin 9.0 (95% CI 8.5-9.6), darker skin 9.1 (95% CI 8.3-9.9), Caucasian 9.1 (95% CI 8.5-9.8), African-American 8.5 (95% CI 7.3-9.8), Asian 7.5 (95% CI 6.4-8.6), and Hispanic 10.1 (95% CI 9.1-11.0). The VF device was worn for an average of 5 min before comfort and ergonomic ratings at their training session. The time required to secure the device onto the operator's head before conducting observations averaged 7.8 (95% CI 7.2 -8.4) s. In the pre-and post-study assessments, 14 operators conducting the study expressed no concerns with the device. Each operator examined an average of 27 subjects. The number of veins viewed was not significantly different by viewer. 
Discussion

Patient characteristic factors
First, the study aimed to delineate how specific patient characteristics impact vein visibility. Anecdotally, physicians believe that extremes of age, obesity, dark skin colour, history of i.v. drug abuse, comorbid vascular conditions such as hypertension, and diabetes make i.v. access more difficult. Veins collapse or constrict with physiological changes such as intravascular volume depletion or increased sympathetic tone, respectively. 6 Visibility of superficial peripheral veins is also attributed to individual body habitus, deposition of adipose tissue, fluid status, blood velocity, and vein diameter. 5 8 For these reasons, the level of difficulty in i.v. access varies significantly based on patient characteristics. Vein counts (range, 0-28 visible veins) showed a strong correlation with age (Fig. 5) , appearing lowest in infants [1.6 (95% CI 1.1 -2.1)] and highest among the elderly [6.8 (95% CI 5.8-7.9)]. We believe that this is due to the relocation of subcutaneous fat into visceral adipose tissue as age increases. 13 14 The regression model indicating infants' reduced number of visible veins should be tempered by the smaller sample size. Comparatively, obese subjects showed a moderately lower number of veins, possibly due to the additional subcutaneous fat reducing hypodermal transparency. 15 Among ethnic groups, the vein count of both African-Americans and Asians decreased farther below the population mean. We did not expect Asians to have fewer veins visible, but perhaps Asians have smaller vessel diameters contributing to reduced visibility. 16 All of our African-American subjects (100%) exhibited darker skin, a probable factor in difficult cases. However, due to our study's broader definition of darker skin with the Von Luschan's chromatic scale, all members of the darker skin colour group averaged 5.4 (95% CI 4.8-6.0), a less dramatic decrease from the population mean. Overall, our hypothesis held true for age and obesity, but ethnicity served as a better predictor of visibility than did skin colour.
We focused on the upper extremity for several reasons. This is a common site of venous cannulation. Although lower extremity veins can also be cannulated, it is usually not the first choice. It was also logistically easier to study forearms and hands as subjects have short sleeves or roll their sleeves up.
While emergency patients would be an interesting group to study, they are often not in the right state of mind to participate, and also likely have more variable acute medical issues that are not easily accounted for or measured in this initial study.
Difficult cases
Whenever patients' veins are invisible to regular eyesight, complications can arise. During these difficult cases, blind cannulation and multiple attempts can be frustrating for medical professionals and painful for patients. Unsuccessful peripheral i.v. cannulation increases the chance of further complications such as bruising, bacterial infection, extravasation, phlebitis, thrombosis, embolism, or nerve damage. 17 It can also lead to even more invasive procedures resulting in higher rates of infection and requiring more operator skill (e.g. central line placement, peripherally inserted central catheters, intraosseous, and venous cut-downs are alternative, more complex techniques). 2 3 In an effort to anticipate difficult i.v. access cases, practitioners habitually rely on patient characteristics (e.g. as extremes of age, obesity, and darker skin colour) as predictors. 7 Our study helped to provide patient characteristic data, defining difficult i.v. access as only occurring in subjects with less than two visible veins using CM (n¼32). Overwhelmingly, infants ran the highest risk (50%) of such cases, although our results are tempered by a smaller sample size. AfricanAmericans and morbidly obese subjects were also markedly high risk. In all, we believe that these characteristics serve as useful predictors for difficult i.v. cannulation cases.
VF technology
To aid in difficult cannulation procedures, practitioners have enlisted the use of various technological devices (e.g. ultrasound). 1 4 7 8 While there are other vein viewing devices with infrared technology, for example, AccuVein w , VeinViewer w , we chose to study one such device. We do not know but have no reason to suspect that there would be major differences than those reported here. Our data analysis has demonstrated the significant enhancement of vein visualization through the use of a new VueTek's Veinsite TM NIR technology. With an overall increase of 3.3 (95% CI 3.0 -3.5), VF consistently improved the average number of visible veins across all patient characteristic categories. In 92% of our cases, the infrared technology allowed the identification of at least one additional vein. There were 14 (3.6%) subjects with fewer veins seen by VF and, in 17 (4.4%) cases, there was no difference. The VF increased the detection of possible i.v. cannulation sites in most (97%) of the difficult cases (n¼32) including 1.7 (95% CI 1.3 -2.1) additional visible vein sites Table 3 for difficult case definition.
for the infant group and 3.7 (95% CI 3.1-4.2) for African-Americans. Obese subjects' vein visibility was also markedly improved by 4.0 (95% CI 3.2-4.8). Morbidly obese patients improved by 3.0 (95% CI 0.9-5.1). In summary, the results agree with our hypothesis, showing the efficacy and broad application of the infrared VF technology. We believe that the device will serve as a convenient, noninvasive tool for identifying potential cannulation sites, particularly for patients with zero or one vein visible as seen by normal eyesight.
When health professionals anticipate or encounter difficult i.v. access, they may consider this new VF technology a viable resource for vein detection. We feel that identifying more veins is one step towards cannulating more veins and that successful and timely i.v. cannulation leads to reduced tissue trauma, reduced economic costs, and higher patient satisfaction. Nonetheless, there is little research about success at cannulating veins that are identified with these new infrared technologies. The NIR technology is not threedimensional, so this is a potential limitation related to the ability to cannulate the veins one sees.
Limitations
Lack of comprehensive interviews with participants implies possible confounding factors. Conditions such as history of i.v. drug abuse, vascular disease, diabetes mellitus, and comorbid hypertension affect visibility of superficial veins and should be included in the above analysis. This study did not use palpation or any supplemental method to increase venous prominence such as fist clenching, proximal venous tourniquet, application of heat, esmarch bandages, application of nitroglycerin ointment, or non-infrared devices such as ultrasound or transillumination. 1 3 6-8 18 19 Future research can investigate the above enumerated methods during actual i.v. cannulation trials.
Conclusion
Our study investigated patient characteristics that influence the identification of veins available for i.v. access. Our findings contribute pertinent and new data on i.v. access. African-American or Asian ethnicity, and obese weight were all patient characteristic groups associated with decreased vein visibility. On average, our practitioners identified approximately six veins on each upper extremity using unassisted vision (CM). The visibility of superficial veins eligible for attempted i.v. cannulation consistently increased when using the new infrared VueTek Veinsite w device. These findings can serve as a basis for future studies. Early identification of patients with difficult i.v. access will lead to better clinical care, preventing complications and reducing delays in starting treatment.
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